Back to Alzheimers Disease
NCT04583033
NCT04583033
Who may be able to join
Who might be able to join this trial:
- You are 55 years of age or older
- You speak English
- You are willing and able to agree to take part in the study
- Your thinking and memory are considered normal (no signs of cognitive problems)
- You have well-documented sleep problems that cause poor sleep quality, based on your own reported experience
Who may not be able to join:
- Women who are pregnant
- People who have thinking or memory difficulties that prevent them from being able to give consent to participate
- People who are currently in prison
- People aged 55 or older who have been diagnosed with mild cognitive impairment (early-stage memory or thinking problems)
- People who have any neurological condition (a condition affecting the brain or nervous system)
- People who have any other condition that the study doctor feels could affect their ability to take part (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University of Miami
Registry
clinicaltrials_gov
Start date
28 September 2021
Est. completion
31 October 2023
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Rate of brain tissue volume loss in specific brain regions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.